Biostime International Holdings Limited : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Analysis
SynopsisICD Research's "Biostime International Holdings Limited : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, financial analysis, mergers & acquisitions, recent developments, key employees, company locations and subsidiaries as well as competitive benchmarking data.
Summary
This report is a crucial resource for industry executives and anyone looking to access key information about "Biostime International Holdings Limited"
The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
• Examines and identifies key information and issues about "Biostime International Holdings Limited" for business intelligence requirements.
• Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
• Provides data on company financial performance and competitive benchmarking.
• The profile also contains information on business operations, company history, major products and services, key employees, and locations and subsidiaries.
Reasons To Buy
• Quickly enhance your understanding of "Biostime International Holdings Limited"
• Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
• Increase business/sales activities by understanding your competitors’ businesses better.
• Recognize potential partnerships and suppliers.
Key Highlights
Biostime International Holdings Limited (Biostime) is a provider of pediatric nutrition and baby care products based in China. The company offers probiotic supplements, infant formula, dried baby food, nutrition supplements and baby care products under five brands: Adimil, Biostime, Parenting Power, BMcare and Mama100. It also offers various value-added services including, professional magazine, mama100 mobile app, nursing consulting hotline, mama100.com website, training program and membership point accumulation program to its members and member retail outlets through its MAMA100 membership platform. The company owns high penetration and wide distribution network through its sales offices located across China. Biostime is headquartered in Guangzhou, China.
ICD Research is a full-service strategic insight provider. We own, manage and build premium panels to help you learn about difficult-to-reach segments and get better ROI from your research budget. We interact with your specific target audiences, using state-of-the-art technology to unlock deeper, quicker and more cost effective insight. ICD is the research and business information arm of Progressive Digital Media Group. ICD provides industry-leading market research and business information. Our products and services help companies make better decisions, win business and position themselves more effectively.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.